HomeNewsIndiaMumbai preparing to vaccinate 50,000 people against COVID-19 daily: Report

Mumbai preparing to vaccinate 50,000 people against COVID-19 daily: Report

COVID-19 vaccination: Authorities have formed 500 teams to vaccinate the population of Mumbai. Eventually, a centre will be opened in every ward to speed-up the process.

January 15, 2021 / 08:55 IST
Story continues below Advertisement
File image: Medics sit inside a vaccination room during a nationwide dry run of COVID-19 vaccine delivery systems, at a temporary vaccination centre in Mumbai, India on January 8, 2021. (Image: Reuters/Niharika Kulkarni)
File image: Medics sit inside a vaccination room during a nationwide dry run of COVID-19 vaccine delivery systems, at a temporary vaccination centre in Mumbai, India on January 8, 2021. (Image: Reuters/Niharika Kulkarni)

Mumbai is setting up facilities to store 1 crore doses of COVID-19 vaccines and preparing to vaccinate 50,000 people daily, Bloomberg reported.

The city, considered India’s financial hub, has been one of the worst-affected urban centres in the country during the novel coronavirus outbreak. Authorities are hoping that a speedy vaccination drive would enable the reopening of establishments and allow further relaxation of lockdown restrictions.

Story continues below Advertisement

Mumbai’s Municipal Commissioner Iqbal Singh Chahal told Bloomberg that the city has formed 500 teams comprising two vaccinators, two support staff, and one guard – based on central guidelines. Initially, 12,000 people will be inoculated daily across eight centres.

However, Additional Municipal Commissioner Suresh Kakani said told Bloomberg that this capacity will rise to 50,000 people daily within a week, subject to availability of vaccine doses and public response. Vaccination centres will eventually be opened in each ward.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show